Blueprint Medicines Corporation (LON:0HOJ)
London flag London · Delayed Price · Currency is GBP · Price in USD
92.13
-3.85 (-4.02%)
At close: Feb 21, 2025

Blueprint Medicines Statistics

Total Valuation

LON:0HOJ has a market cap or net worth of GBP 4.66 billion. The enterprise value is 4.55 billion.

Market Cap 4.66B
Enterprise Value 4.55B

Important Dates

The last earnings date was Friday, February 14, 2025.

Earnings Date Feb 14, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +3.80%
Shares Change (QoQ) +0.35%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 63.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 19.55
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -84.96
EV / Sales 11.31
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -28.90

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 2.43.

Current Ratio 2.85
Quick Ratio 2.66
Debt / Equity 2.43
Debt / EBITDA n/a
Debt / FCF -3.67
Interest Coverage -3.08

Financial Efficiency

Return on equity (ROE) is -31.26% and return on invested capital (ROIC) is -13.75%.

Return on Equity (ROE) -31.26%
Return on Assets (ROA) -11.89%
Return on Invested Capital (ROIC) -13.75%
Return on Capital Employed (ROCE) -23.07%
Revenue Per Employee 626,246
Profits Per Employee -82,571
Employee Count 649
Asset Turnover 0.46
Inventory Turnover 1.16

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +1.35% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +1.35%
50-Day Moving Average 99.85
200-Day Moving Average 98.62
Relative Strength Index (RSI) 35.00
Average Volume (20 Days) 285

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.96

Income Statement

In the last 12 months, LON:0HOJ had revenue of GBP 406.43 million and -53.59 million in losses. Loss per share was -0.85.

Revenue 406.43M
Gross Profit 390.33M
Operating Income -169.37M
Pretax Income -52.61M
Net Income -53.59M
EBITDA -156.36M
EBIT -169.37M
Loss Per Share -0.85
Full Income Statement

Balance Sheet

The company has 491.63 million in cash and 578.53 million in debt, giving a net cash position of 111.55 million.

Cash & Cash Equivalents 491.63M
Total Debt 578.53M
Net Cash 111.55M
Net Cash Per Share n/a
Equity (Book Value) 238.56M
Book Value Per Share 3.74
Working Capital 384.91M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -153.83 million and capital expenditures -3.70 million, giving a free cash flow of -157.53 million.

Operating Cash Flow -153.83M
Capital Expenditures -3.70M
Free Cash Flow -157.53M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 96.04%, with operating and profit margins of -41.67% and -13.19%.

Gross Margin 96.04%
Operating Margin -41.67%
Pretax Margin -12.94%
Profit Margin -13.19%
EBITDA Margin -38.47%
EBIT Margin -41.67%
FCF Margin n/a

Dividends & Yields

LON:0HOJ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.80%
Shareholder Yield -3.80%
Earnings Yield -1.15%
FCF Yield -3.38%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

LON:0HOJ has an Altman Z-Score of 1.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.48
Piotroski F-Score n/a